Cochlear

Cochlear EBIT per Employee

The EBIT per Employee of Cochlear (COH.AX) as of Oct 4, 2026 is 75,250.00 AUD. In the previous year, EBIT per Employee was 101,525.00 AUD — a change of -25.88% (lower).

EBIT per Employee

75,250.00AUD

YoY

-25.88%

Last updated:

EBIT per Employee of Cochlear is 2026 75,250.00 AUD. EBIT per Employee of Cochlear was 2025 101,525.00 AUD. It decreases by -25.88% lower compared to the previous year.

The Cochlear EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2019
89,350.00 AUD
Jan 1, 2020
64,750.00 AUD
Jan 1, 2021
84,075.00 AUD
Jan 1, 2022
91,975.00 AUD
Jan 1, 2023
97,375.00 AUD
Jan 1, 2024
130,375.00 AUD
Jan 1, 2025
101,525.00 AUD
Jan 1, 2026
75,250.00 AUD
The Cochlear EBIT per Employee history
YEAREBIT per EmployeeYoY
75,250.00AUD-25.88%
101,525.00AUD-22.13%
130,375.00AUD+33.89%
97,375.00AUD+5.87%
91,975.00AUD+9.40%
84,075.00AUD+29.85%
64,750.00AUD-27.53%
89,350.00AUD+3.53%
86,300.00AUD+9.52%
78,800.00AUD+20.19%
65,561.75AUD+27.78%
51,307.50AUD+34.36%
38,187.00AUD—
Access this data via the Eulerpool API

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

EBIT per Employee of Cochlear is 75,250.00 AUD in 2026.

EBIT per Employee of Cochlear changed from 101,525.00 AUD to 75,250.00 AUD, representing a -25.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Cochlear since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Cochlear historically and in real time.

Access this data via the Eulerpool API

Workforce — Cochlear

All Key Metrics — Cochlear